‘Excellent outcome’: New diabetic CKD drug option for GPs

Monitor serum potassium a month after patients start finerenone, recommends a leading nephrologist.
Rachel Fieldhouse
Professor Carol Pollock
Professor Carol Pollock.

GPs can now prescribe finerenone under the PBS to prevent worsening kidney function in adults with chronic kidney disease caused by type 2 diabetes.

More than 26,000 patients with diabetic chronic kidney disease (CKD) who are still at risk of declining renal function despite first-line therapy are expected to benefit from the new listing, which went live on 1 July.